Inhibition of Coxsackievirus B3 Replication by Small Interfering RNAs Requires Perfect Sequence Match in the Central Region of the Viral Positive Strand

Coxsackievirus B3 (CVB3) is the most common causal agent of viral myocarditis, but existing drug therapies are of limited value. Application of small interfering RNA (siRNA) in knockdown of gene expression is an emerging technology in antiviral gene therapy. To investigate whether RNA interference (...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	J Virol
Autori principali:	Yuan, Ji, Cheung, Paul K. M., Zhang, Huifang M., Chau, David, Yang, Decheng
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 2005
Soggetti:	Vaccines and Antiviral Agents
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC546545/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15681418/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.79.4.2151-2159.2005
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!